3 -

3 - Thielen N, Van der Holt B, Cornelissen J, et al. Imatinib discontinuation in chronic phase myeloid leukaemia patients in sustained complete molecular response: A randomised trial of the Dutch–Belgian Cooperative Trial for Haemato-Oncology (HOVON). European Journa]l of Cancer (2013) 49, 3242– 3246. [link]